Ansell saw the highest growth of 0.99% in patent filings in May and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.32% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Ansell’s patent filings and grants. Buy the databook here.
Ansell has been focused on protecting inventions in European Patent Office(EPO) with two publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 67% of filings. The European Patent Office(EPO), World Intellectual Property Organization(WIPO), and United States(US) patent Office are among the top ten patent offices where Ansell is filings its patents. Among the top granted patent authorities, Ansell has 100% of its grants in United States(US).
Midori Anzen and Zeon could be the strongest competitors for Ansell
In terms of grant share, Ansell stands in fourth position among its competitors. Midori Anzen and Zeon secured the top positions according to recent patent publication data.
Patents related to workplace safety and healthtech lead Ansell's portfolio
Ansell has the highest number of patents in workplace safety followed by, healthtech and connected patient. For workplace safety, nearly 33% of patents were filed and 100% of patents were granted in Q2 2024.
Petrochemicals related patents lead Ansell portfolio followed by hospital supplies
Ansell has highest number of patents in petrochemicals followed by hospital supplies. For petrochemicals, nearly 50% of patents were filed and 100% of patents were granted in Q2 2024.
For comprehensive analysis of Ansell's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.